ACXP Earnings — Acurx Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
ACXP — Acurx Pharmaceuticals, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.98
Market Cap$8.5M
P/E—
52W Range$1.33 – $21.00
Next Earnings2026-08-11
About Acurx Pharmaceuticals, Inc. Common Stock
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
